Literature DB >> 35693401

Genomic alterations in hepatocellular carcinoma and their clinical application to genomic medicine.

Taisuke Imamura1, Yukiyasu Okamura1,2.   

Abstract

Entities:  

Year:  2022        PMID： 35693401      PMCID： PMC9186203          DOI： 10.21037/hbsn-22-135

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  15 in total

Review 1.  A second chance for telomerase reverse transcriptase in anticancer immunotherapy.

Authors:  Maurizio Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

2.  Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.

Authors:  Sung-Min Ahn; Se Jin Jang; Ju Hyun Shim; Deokhoon Kim; Seung-Mo Hong; Chang Ohk Sung; Daehyun Baek; Farhan Haq; Adnan Ahmad Ansari; Sun Young Lee; Sung-Min Chun; Seongmin Choi; Hyun-Jeung Choi; Jongkyu Kim; Sukjun Kim; Shin Hwang; Young-Joo Lee; Jong-Eun Lee; Wang-Rim Jung; Hye Yoon Jang; Eunho Yang; Wing-Kin Sung; Nikki P Lee; Mao Mao; Charles Lee; Jessica Zucman-Rossi; Eunsil Yu; Han Chu Lee; Gu Kong
Journal:  Hepatology       Date:  2014-09-22       Impact factor: 17.425

3.  ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.

Authors:  Jianfeng Shen; Zhenlin Ju; Wei Zhao; Lulu Wang; Yang Peng; Zhongqi Ge; Zachary D Nagel; Jun Zou; Chen Wang; Prabodh Kapoor; Xiangyi Ma; Ding Ma; Jiyong Liang; Shumei Song; Jinsong Liu; Leona D Samson; Jaffer A Ajani; Guo-Min Li; Han Liang; Xuetong Shen; Gordon B Mills; Guang Peng
Journal:  Nat Med       Date:  2018-05-07       Impact factor: 53.440

4.  Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients.

Authors:  Shuo Wang; Huasheng Shi; Tao Liu; Manjiang Li; Sanshun Zhou; Xuan Qiu; Zusen Wang; Weiyu Hu; Weidong Guo; Xiaoqian Chen; Honglin Guo; Xiaoliang Shi; Junping Shi; Yunjin Zang; Jingyu Cao; Liqun Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2021-04       Impact factor: 8.265

5.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.

Authors:  Kornelius Schulze; Sandrine Imbeaud; Eric Letouzé; Ludmil B Alexandrov; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Clément Meiller; Jayendra Shinde; Frederic Soysouvanh; Anna-Line Calatayud; Roser Pinyol; Laura Pelletier; Charles Balabaud; Alexis Laurent; Jean-Frederic Blanc; Vincenzo Mazzaferro; Fabien Calvo; Augusto Villanueva; Jean-Charles Nault; Paulette Bioulac-Sage; Michael R Stratton; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Nat Genet       Date:  2015-03-30       Impact factor: 38.330

6.  The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.

Authors:  Tomi Akinyemiju; Semaw Abera; Muktar Ahmed; Noore Alam; Mulubirhan Assefa Alemayohu; Christine Allen; Rajaa Al-Raddadi; Nelson Alvis-Guzman; Yaw Amoako; Al Artaman; Tadesse Awoke Ayele; Aleksandra Barac; Isabela Bensenor; Adugnaw Berhane; Zulfiqar Bhutta; Jacqueline Castillo-Rivas; Abdulaal Chitheer; Jee-Young Choi; Benjamin Cowie; Lalit Dandona; Rakhi Dandona; Subhojit Dey; Daniel Dicker; Huyen Phuc; Donatus U. Ekwueme; Maysaa El Sayed Zaki; Florian Fischer; Thomas Fürst; Jamie Hancock; Simon I. Hay; Peter Hotez; Sun Ha Jee; Amir Kasaeian; Yousef Khader; Young-Ho Khang; Anil Kumar; Michael Kutz; Heidi Larson; Alan Lopez; Raimundas Lunevicius; Reza Malekzadeh; Colm McAlinden; Toni Meier; Walter Mendoza; Ali Mokdad; Maziar Moradi-Lakeh; Gabriele Nagel; Quyen Nguyen; Grant Nguyen; Felix Ogbo; George Patton; David M. Pereira; Farshad Pourmalek; Mostafa Qorbani; Amir Radfar; Gholamreza Roshandel; Joshua A Salomon; Juan Sanabria; Benn Sartorius; Maheswar Satpathy; Monika Sawhney; Sadaf Sepanlou; Katya Shackelford; Hirbo Shore; Jiandong Sun; Desalegn Tadese Mengistu; Roman Topór-Mądry; Bach Tran; Vasiliy Vlassov; Stein Emil Vollset; Theo Vos; Tolassa Wakayo; Elisabete Weiderpass; Andrea Werdecker; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Zoubida Zaidi; Liguo Zhu; Christopher J. L. Murray; Mohsen Naghavi; Christina Fitzmaurice
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

Review 7.  Telomerase-Targeted Cancer Immunotherapy.

Authors:  Eishiro Mizukoshi; Shuichi Kaneko
Journal:  Int J Mol Sci       Date:  2019-04-12       Impact factor: 5.923

8.  Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.

Authors:  Nikolaus Schultz; Ghassan K Abou-Alfa; James J Harding; Subhiksha Nandakumar; Joshua Armenia; Danny N Khalil; Melanie Albano; Michele Ly; Jinru Shia; Jaclyn F Hechtman; Ritika Kundra; Imane El Dika; Richard K Do; Yichao Sun; T Peter Kingham; Michael I D'Angelica; Michael F Berger; David M Hyman; William Jarnagin; David S Klimstra; Yelena Y Janjigian; David B Solit
Journal:  Clin Cancer Res       Date:  2018-10-29       Impact factor: 12.531

9.  Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.

Authors: 
Journal:  Cell       Date:  2017-06-15       Impact factor: 66.850

10.  Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations.

Authors:  Masashi Fujita; Rui Yamaguchi; Takanori Hasegawa; Shu Shimada; Koji Arihiro; Shuto Hayashi; Kazuhiro Maejima; Kaoru Nakano; Akihiro Fujimoto; Atsushi Ono; Hiroshi Aikata; Masaki Ueno; Shinya Hayami; Hiroko Tanaka; Satoru Miyano; Hiroki Yamaue; Kazuaki Chayama; Kazuhiro Kakimi; Shinji Tanaka; Seiya Imoto; Hidewaki Nakagawa
Journal:  EBioMedicine       Date:  2020-02-26       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.